{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:54Z","timestamp":1792047834403,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":380,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.immuni.2017.04.025","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T12:17:16Z","timestamp":1494937036000},"page":"875-890.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":505,"title":["Interferon-\u03bb Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness"],"prefix":"10.1016","volume":"46","author":[{"given":"Ioanna E.","family":"Galani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Triantafyllia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evridiki-Evangelia","family":"Eleminiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Koltsida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Manioudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"Kotenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Thanopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Andreakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2017.04.025_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2017.04.025_bib2","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFN-\u03bb resolves inflammation via suppression of neutrophil infiltration and IL-1\u03b2 production","volume":"212","author":"Blazek","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2017.04.025_bib4","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.immuni.2017.04.025_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2013.06.013","article-title":"A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection","volume":"154","author":"Brandes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2017.04.025_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2017.04.025_bib7","doi-asserted-by":"crossref","first-page":"e1003773","DOI":"10.1371\/journal.ppat.1003773","article-title":"Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia","volume":"9","author":"Crotta","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2017.04.025_bib8","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1182\/blood-2008-09-179507","article-title":"IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T\u00a0cells","volume":"113","author":"Dai","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2017.04.025_bib9","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/ncomms4864","article-title":"Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection","volume":"5","author":"Davidson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2017.04.025_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15252\/emmm.201606413","article-title":"IFN\u03bb is a potent anti-influenza therapeutic without the inflammatory side effects of IFN\u03b1 treatment","volume":"8","author":"Davidson","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.immuni.2017.04.025_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12101","article-title":"Interferon induction and function at the mucosal surface","volume":"255","author":"Durbin","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2017.04.025_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.4VMR1114-555R","article-title":"Neutrophils in viral infections: Current concepts and caveats","volume":"98","author":"Galani","year":"2015","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.immuni.2017.04.025_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-15774-0_1","article-title":"Type III interferons (IFNs): emerging master regulators of immunity","volume":"850","author":"Galani","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.immuni.2017.04.025_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-\u03bb and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","author":"Hern\u00e1ndez","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2893.2012.01610.x","article-title":"Distinct and overlapping genomic profiles and antiviral effects of interferon-\u03bb and -\u03b1 on HCV-infected and noninfected hepatoma cells","volume":"19","author":"Kohli","year":"2012","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.immuni.2017.04.025_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.immuni.2017.04.025_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib19","doi-asserted-by":"crossref","first-page":"284ra59","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2017.04.025_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: Immune Functions at Barrier Surfaces and Beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2017.04.025_bib21","doi-asserted-by":"crossref","first-page":"e1005600","DOI":"10.1371\/journal.ppat.1005600","article-title":"Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections","volume":"12","author":"Lin","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2017.04.025_bib22","doi-asserted-by":"crossref","first-page":"e1004782","DOI":"10.1371\/journal.ppat.1004782","article-title":"Leukocyte-derived IFN-\u03b1\/\u03b2 and epithelial IFN-\u03bb constitute a compartmentalized mucosal defense system that restricts enteric virus infections","volume":"11","author":"Mahlak\u00f5iv","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2017.04.025_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2017.04.025_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2017.02.017","article-title":"The IFN-\u03bb-IFN-\u03bbR1-IL-10R\u03b2 complex reveals structural features underlying type III IFN functional plasticity","volume":"46","author":"Mendoza","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2017.04.025_bib26","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T\u00a0cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2017.04.025_bib27","doi-asserted-by":"crossref","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2017.04.025_bib28","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2017.04.025_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hep.23743","article-title":"Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection","volume":"52","author":"Muir","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.immuni.2017.04.025_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-\u03bb cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2017.04.025_bib31","first-page":"11","article-title":"Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm","volume":"3","author":"Okubo","year":"2004","journal-title":"J.\u00a0Biol."},{"key":"10.1016\/j.immuni.2017.04.025_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2004.10.010","article-title":"JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells","volume":"119","author":"Passegu\u00e9","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2017.04.025_bib33","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-lambda determines the intestinal epithelial antiviral host defense","volume":"108","author":"Pott","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2017.04.025_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2017.04.025_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2017.04.025_bib36","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1128\/AAC.01664-12","article-title":"Exacerbation of influenza virus infections in mice by intranasal treatments and implications for evaluation of antiviral drugs","volume":"56","author":"Smee","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.immuni.2017.04.025_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat. Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761317301905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761317301905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T16:32:04Z","timestamp":1535819524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761317301905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1074761317301905"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2017.04.025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727620484.793535000","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03bb Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2017.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}